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Successful devascularization of carotid body
tumors by covered stent placement in the external
carotid artery
James M. Scanlon, MD,a Jacob J. Lustgarten, MD,b Stewart B. Karr, MD,c and Jules I. Cahan, MD,d
Washington, DC; and Silver Spring, Md
Management of highly vascular carotid body tumors can involve pre-operative percutaneous embolization before
definitive surgical resection. This step reduces tumor size, reduces operative blood loss, and makes for a less hazardous
dissection with the goal of reducing morbidity and mortality. The effectiveness of a recently described technique of
interrupting vascular supply via covered stent placement in the external carotid artery is further described in a series of
three recent cases. This technique may be useful for large tumors with a primary blood supply from the external carotid
since it avoids the intracranial embolic risk of coils used for this purpose. ( J Vasc Surg 2008;48:1322-4.)Tumors of the carotid body (CBT) are uncommon
neoplasms that arise from the paraganglion cells within
these organs.1 Surgical resection is usually indicated for
symptoms due to growth and to exclude malignancy.1-2
Historically, surgical resection of these hypervascular tu-
mors can incur significant blood loss and can carry signifi-
cant risk of stroke and cranial nerve injury.3-5 Present-day
management of these tumors, particularly larger ones, of-
ten includes pre-operative vascular exclusion through em-
bolization of feeder vessels. Vascular exclusion has been
shown to reduce blood loss, shrink tumor bulk, and make
dissection and resection easier,1,4,6,7 but the embolization
procedure itself can be quite tedious and hazardous in its
own right.5 In 2003, Tripp et al8 reported on a new
technique of achieving “devascularization” of a CBT with
theoretically less risk than embolization. We report on our
recent results using this same approach of covered stent
placement in the external carotid artery in three patients.
CASE REPORT
All 3 patients (2 males ages 40 and 68, 1 female age 51)
presented with a slowly enlarging neck mass. Duplex ultrasonog-
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1322raphy scan was performed initially on all 3 patients demonstrating
a hypervascular mass located at and splaying the carotid bifurca-
tion. Our patients had either computed tomographic angiography
(CTA) or magnetic resonance angiography (MRA) as part of their
work-up demonstrating a hypervascular mass ranging in size of 3.7
cm to 5.0 cm (37 to 59 cm3). Each patient had arch aortograms
and cerebral arteriograms performed via femoral access under local
anesthesia by one operator (S.K.). The images were carefully
interpreted in order to identify the blood supply to the tumor.
Each patient was noted to have more than one major vessel from
the external carotid artery feeding the tumor, there were no
branches to or from the vertebral or internal carotid arteries identified.
As expected, the arteries most commonly involved were the supe-
rior thyroid, ascending pharyngeal, lingual, and occipital arteries.
Guidewire access of the external carotid artery was then obtained
and vessel measurements were made in order to plan stent place-
ment to cover all feeding branches. Overlapping JOMED JOSTENT
GraftMaster (JOMED,Helsingborg, Sweden) coronary stent grafts
were then positioned via a balloon-tipped delivery system and
dilated to exclude the targeted branches andmatch the target vessel
diameter with up to 1mmof overdilation. Two patients required two
26-mm long stent grafts and the third required an additional 16-mm
stent graft. Angiography performed after stent insertion showed no
dissections or extravasation of contrast (Figs 1 and 2). There were no
complications from the procedure and each patient was admitted
as an in-patient until their operation.
Within 24-48 hours of the stent placement, each patient was
taken to the operating room where they had complete resection of
their tumor under general anesthesia by the same vascular surgeon
(J.L.). Dissection was carried out as described byGordon-Taylor in
the peri-adventitial plane with low rates of blood loss.2,9 The
estimated blood loss ranged from 200 cc to 600 cc and averaged
367 cc. The dissection of the tumor, even where it appeared quite
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bleeding. Resection performed within 48 hours of stent placement
appeared optimal in regards to achieving vascular exclusion while
avoiding the onset of inflammation and neo-vascularization. Al-
though the regional anatomy was distorted due to the mass effect
of the tumors, all vagus and hypoglossal nerves were readily iden-
tified and preserved. The patient with the largest blood loss
(600 cc) had a tumor that was encircling the external carotid artery
and very adherent to the bifurcation. In this case, safe resection
required resecting it en-bloc after ligating and dividing the external
carotid artery above the stent and reconstructing the bifurcation
with an interposition vein graft between the common and internal
carotid arteries. Because of its invasiveness, this tumor was classi-
fied a Shamblin 3 (the others were Shamblin 1). The other two
tumors were able to be resected leaving the carotid arteries intact.
Analysis of all specimens confirmed the presence of paragangliomas
of the carotid body without evidence ofmalignancy. There were no
strokes as a result of the operation. All 3 patients had some mild
cranial nerve dysfunction postoperatively. One patient experienced
a transient weakness of the marginal branch of the mandibular
nerve which resolved within a few weeks. The patient who had the
interposition graft had a mild Horner’s syndrome with unilateral
pupillary constriction that also resolved. The third had mild vocal
cord dysfunction that resolved over a few months. Follow-up
ranged from 23 to 36 months with no other morbidities or deaths.
DISCUSSION
Surgical resection of CBTs has historically been associ-
ated with significant mortality and morbidity, mostly from
extensive blood loss, cranial nerve injury, and stroke.3-6
Fig 1. Pre-stenting angiogram demonstrating a carotid body tu-
mor in a 40-year-old man.The evolution of surgical management of CBTs regardingtechnique andpre- and intra-operativemeasures has sought to
address these difficulties. Pre-operative tumor embolization
has become a possible approach in an effort to minimize
blood loss and thereby, in theory, make the dissection less
hazardous and reduce the incidence of cranial nerve injury
and stroke.1,4,7 First described in the early 1980s, this
procedure has been well described and accepted with low
complication rates.10,11 Several studies have, in fact, attrib-
uted to the significant reduction in blood loss and simpli-
fication of dissection as leading to lower rates of stroke and
even mortality.4-6,12-16 These studies have shown a dra-
matic reduction in blood loss with amounts of roughly
one-third of that seen without embolization. However, in
most of these series, as in this one, the incidence of cranial
nerve injury is still significant. In both resection with and
without embolization, as in this series, the vast majority of
cranial nerve injuries are temporary and resolve spontaneously.
Several authors have suggested that this complication seems
more a function of tumor invasiveness and not the reduction
in blood loss.4,7 The act of embolization itself can incur risk of
stroke which underscores the potential dangers involved in
tumor embolization and the need for skilled expertise to
perform these often long and tedious interventions.3,5-7,15,17
External carotid artery stenting, first described in 2003,
has thus far only been described in a single case report.
However, the results of the original case and the current
series are encouraging in terms of success of the procedure
Fig 2. Post-stenting angiogram demonstrating vascular exclusion
of the carotid body tumor. At surgery the tumor was found to be
enveloping the external carotid artery.in reducing operative blood loss and yielding minimal
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embolization. Covering the branches of the external ca-
rotid artery from the origin to the level of the highest feeder
artery also excludes any smaller, angiographically unseen
vessels. In addition, there are usually several vessels feeding
the tumor, each one requiring the painstaking and meticu-
lous proper positioning and careful delivery of emboliza-
tion agent. This can be very time consuming and each step
introduces the risk of unwanted distal embolization. As
pointed out by Tripp et al,7 the deployment of a covered
stent may be less challenging and time consuming for many
interventionalists in comparison to embolization that can
have success rates as low as 81%. It is hypothesized that
there would be a lower stroke risk with stenting as com-
pared with embolization as there are no particulate embolic
agents introduced that could cause nontarget organ embo-
lization or traverse across “dangerous anastomosis” into
the cerebral circulation. This stroke risk, albeit small, is hard
to define based solely on case reports.5,17 Whether this
technique will improve upon the total management of CBT
will require more experience, but its role in dealing with
large and/or invasive tumors appears beneficial. We feel
our experience with this technique is further testament of
an apparently safe and effective alternative strategy for
treating these difficult tumors.
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